Assuming it is clinically indicated, would a checkpoint inhibitor be efficacious in a patient who has a concurrent autoimmune illness (PMR/TA) and is on prednisone? Is low dose prednisone acceptable or would immunotherapy be contraindicated in this case? If so, what is the dose cut-off?